|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Varenieline, an α4β2 nicotinic acetyleholine receptor partial agonist, vs sustainted-release bupropion and placebo for smoking cessation: a randomized controlled trial 显示文摘 | Gonzales D Rennard SI Nide M | 2006 | JAMA2006，296，： | 1 |
| 2 | Smoking cessation with varenicline,a selective alpha4beta2 nicotinic receptor partial agonist:results from a 7-week,randomized,placebo-and bupropion-controlled trial with 1-year follow-up显示文摘 | Nides M Oncken C Gonzales D | 2006 | Arch Intern Med2006，166，15： | 1 |
| 3 | Varenicline,an alpha4be-ta2 nicotinic acetylcholine receptor partial agonist,vs sustained-release bupropion and placebo for smoking cessation:a randomized controlled trial显示文摘 | Gonzales D Rennard SI Nides M | 2006 | JAMA2006，296，1： | 1 |
| 4 | Varenicline, an ct4132 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation and a randomized controlled trial显示文摘 | Gonzales D Rennard SI Nides M | 2006 | JAMA2006，296，1： | 1 |
| 5 | Varenicline, analpha4beta2 nicotinic acetylcholine receptor partial ago- nist, vs sustained-release bupropion and placebo for sm- oking cessation: A randomized controlled trial显示文摘 | Gonzales D Rennard SI Nides M | 2006 | JAMA2006，296，1： | 1 |
| 6 | Varenicline,an alpha4beta2 nicotinic acetylcholine receptor partial agonist,vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial显示文摘 | Gonzales D Rennard SI Nides M | 2006 | J Am Med Assoc2006，296，1： | 1 |
| 7 | A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation显示文摘 | Jorenby D E Leischow S J Nides M A | 1999 | N Engl J Med1999，340，9： | 1 |
| 8 | Varenicline, an 42 nicotinic acetylcholine receptor partial agonist, vs sus- tained-release bupropion and placebo for smoking cessation 显示文摘 | GONZALES D RENNARD SI NIDES M | 2006 | JAMA2006，296，1： | 1 |
| 9 | Varenicline,anα4β2nicotinic acetylcholine receptor partial agonist,vs sustained-release bupropion and placebo for smoking cessation:a randomized controlled trial显示文摘 | Gonzales D Rennard SI Nides M | 2006 | JAMA2006，296，1： | 1 |
| 10 | Varenicline, an alpha4beta2 nicotinic aeetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial显示文摘 | GONZALES D RENNARD SI NIDES M et ol | 2006 | JAMA2006，296，1： | 1 |
| 11 | Metered-dose inhaler adherence in a clinical trial显示文摘 | Rand CS Wise RA Nides M | 1992 | Am Rev Respir Dis1992，146，： | 1 |
| 12 | Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation : a randomized controlled trial 显示文摘 | Gonzales D Rennard S I Nides M | 2006 | JAMA2006，296，1： | 1 |
| 13 | Smoking cessation withvarenicline, a selective alpha4beta2 nicotinic receptor partial ago-nist:results from a 7-week, randomized, placebo-and bupropion-controlled trial with 1-year follow-up显示文摘 | Nides M Oncken C Gonzales D | 2006 | Arch Intern Med2006，166，15： | 1 |
| 14 | Efficacy and safety of thenovel selective nicotinic acetylcholine receptor partial agonist,varenicline,for smoking cessation显示文摘 | Oncken C Gonzales D Nides M | 2006 | Arch Intern Med2006，166，15： | 1 |
| 15 | Metered-dose inhaler adherence in a clinical trial显示文摘 | Rand CS Wise RA Nides M | 1992 | Am Rev Respir Dis1992，146，： | 1 |
| 16 | Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial ago- nist: results from a 7-week, randomized, placebo- and buprepion- controlled trial with 1-year follow-up 显示文摘 | Nides M Oncken C Gonzales D | 2006 | Arch Intern Med2006，166，15： | 1 |
| 17 | Varenicline, an alpha4beta2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Re- lease Bupropion and Placebo for Smoking Cessation: a randomized controlled trial 显示文摘 | Gonzales D Rennard SI Nides M | 2006 | JAMA2006，296，1： | 1 |
| 18 | Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo 显示文摘 | Jamerson BD Nides M Jorenby DE | 2001 | Clin Ther2001，23，5： | 1 |
| 19 | Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation显示文摘 | Oncken C Gonzales D Nides M | 2006 | Arch Intern Med2006，166，15： | 1 |
| 20 | Vareni-cline,an a4b2 nicotinic acetylcholine receptor partial agonist,vs sustaine drelease bupropion and placebo for smoking cessation:a randomized controlled trial显示文摘 | GONZALES D RENNARD S I NIDE S M | 2006 | JAMA2006，296，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员